Probiotics have a limited role in the treatment of inflammatory bowel disease;Beperkte rol voor probiotica bij behandeling van inflammatoir darmlijden

Nederlands Tijdschrift voor Geneeskunde

Volumn 156, Issue 41, 2012, Pages

  Dieleman, Levinus A ^a   Hoentjen, Frank ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ENTERITIS; HUMAN; NOTE; ARTICLE; EVIDENCE BASED MEDICINE; ILEITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

EVIDENCE-BASED MEDICINE; HUMANS; INFLAMMATORY BOWEL DISEASES; POUCHITIS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84873638913     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. World Health Organization. Guidelines for the evaluation of probiotics in food. Report of a joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food, London Ontario, Canada; 2002, www.fda.gov/ohrms/dockets/dockets/95s0316/95s-0316-rpt0282-tab-03-ref-19-joint- faowho-vol219.pdf, geraadpleegd op 10 augustus 2012.
2. Jonkers D, Penders J, Masclee A, Pierik M. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients. Drugs. 2012;72:803-23.
3. Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, Talbot IC, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut. 2004;53:108-14.
4. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119:305-9.
5. Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, Brigidi P, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology. 2003;124:1202-9.
6. Shen B, Brzezinski A, Fazio VW, Remzi FH, Achkar JP, Bennett AE, et al. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Aliment Pharmacol Ther. 2005;22:721-8.
7. Adham K, Dougherty T, Sardana N, Borum M. Buyer beware: therapeutic claims of probiotics marketed to Crohn's disease patients via the internet lack supporting data. Inflamm Bowel Dis. 2012;18:597.
8. Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371:651-9.
9. Van Bodegraven AA, van Everdingen JJ, Dijkstra G, de Jong DJ, Oldenburg B, Hommes DW. Richtlijn 'Diagnostiek en behandeling van inflammatoire darmziekten bij volwassenen'. I. Diagnostiek en behandeling. Ned Tijdschr Geneeskd. 2010;154:A1899.
10. Tursi A, Brandimarte G, Papa A, Giglio A, Elisei W, Giorgetti GM, et al. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2010;105:2218-27.